Philippines Seeks To Invalidate Pfizer Patent
A federal appeals court ruling last month which invalidated a patent covering Pfizer Inc.'s blockbuster hypertension drug Norvasc has spawned an effort to invalidate the patent in the Philippines....To view the full article, register now.
Already a subscriber? Click here to view full article